Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein-Reference-Cited by-同舟云学术

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein

Published:2018-08 Issue:2 Volume:84 Page:315-328
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Spadaro Melania¹,Winklmeier Stephan¹,Beltrán Eduardo¹,Macrini Caterina¹,Höftberger Romana²,Schuh Elisabeth¹,Thaler Franziska S.¹,Gerdes Lisa Ann¹,Laurent Sarah¹,Gerhards Ramona¹,Brändle Simone¹,Dornmair Klaus¹,Breithaupt Constanze³,Krumbholz Markus⁴,Moser Markus⁵,Krishnamoorthy Gurumoorthy⁵,Kamp Frits⁶,Jenne Dieter⁷,Hohlfeld Reinhard¹⁸,Kümpfel Tania¹,Lassmann Hans⁹,Kawakami Naoto¹,Meinl Edgar¹

Affiliation:

1. Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals; Ludwig-Maximilians-Universität München; Munich Germany

2. Institute of Neurology; Medical University of Vienna; Vienna Austria

3. Department of Physical Biotechnology; Martin Luther University of Halle-Wittenberg; Halle Germany

4. Department of Neurology and Hertie Institute for Clinical Brain Research; Eberhard Karl University; Tübingen Germany

5. Max Planck Institute of Biochemistry; Martinsried Germany

6. Department of Biophysics, Biomedical Center; Ludwig Maximilian University of Munich; Munich Germany

7. Comprehensive Pneumology Center (CPC); Institute of Lung Biology and Disease, Helmholtz Zentrum München, Munich, and Max Planck Institute of Neurobiology; Planegg-Martinsried Germany

8. Munich Cluster for Systems Neurology; Munich Germany

9. Center for Brain Research; Medical University of Vienna; Austria

Funder

German Research Foundation

Munich Cluster for Systems Neurology

Clinical Competence Network for Multiple Sclerosis

Hertie Foundation

Novartis Foundation

EU Framework Programme for Research and Innovation H2020

Werner Reichenberger Foundation

Publisher

Wiley